San Francisco, California
London, United Kingdom
On Saturday, September 7th, 2013 the Macular Degeneration Association(MDA)will host a unique awareness program in Hauppauge, NY. The event is designed to give an overview of age-related macular degeneration(AMD), including the progression of the disease and the dangers of vision loss as a result. The symposium will also cover precautionary methods that may delay the onset of AMD and reduce retinal damage.
Event attendees will learn the latest treatment advances evolving in the macular field. In addition you will hear from a patient that has macular degeneration, their journey and tips on handling this disease.
Exhibitors and featured event speakers will offer participants many opportunities to learn about the latest advances in macular degeneration research, precautionary methods,medications, treatments, and low vision therapies.
MDA’s awareness program in Hauppauge will provide attendees with a unique opportunity to interact with macular experts, local doctors, fellow patients and caregivers in an open forum.
Macular Degeneration Association - Chairman
Mr. Hoffheimer practiced healthcare law in Washington, DC for 35 years. Prior to that, he served as a federal prosecutor with the United States Department of Justice. During the course of his law career, he represented numerous voluntary health agencies and healthcare professionals. Mr. Hoffheimer formed and led the advocacy effort that resulted in the Congressional Resolution and Presidential Proclamation declaring the1990s as the Decade of the Brain. In 2003, Mr. Hoffheimer formed the Macular Degeneration Association (MDA) and moved to Sarasota, Florida where he is currently the MDA Chairman.
Ken Carnevale, MD
Dr. Carnevale is an assistant clinical professor of Ophthalmology at The New York Presbyterian Hospital in Manhattan and practices locally on Long Island, at Ophthalmic Consultants of Long Island. He graduated summa cum laude and Phi Beta Kappa from Boston University. He received his Doctorate of Medicine from the New Jersey School of Medicine. Dr. Carnevale then completed an internship at the Multi-Specialty Lahey Clinic Medical Center in Burlington, Massachusetts and his Ophthalmology residency at The New York Hospital- Cornell Medical Center. During his training in vitroretinal surgery at The New York Presbyterian Hospital, Dr. Carnevale participated in several clinical trials for AMD. He is a board certified member of several medical societies.
Glenn Stoller, MD
Dr. Stoller is a Board Certified Ophthalmologist specializing in medical and surgical diseases of the retina. He graduated Phi Beta Kappa and summa cum laude from the University of Rochester with a Bachelor’s degree in Neuroscience and received his medical degree from New York University of Medicine. Dr. Stoller completed his ophthalmology residency at The Harkness Eye Institute at Columbia Presbyterian Hospital in New York. He has served as a clinical instructor in ophthalmology at New York Hospital at Cornell Medical Center and as the assistant clinical professor at New York Presbyterian Hospital, Weill Medical College, and New York University Hospital. Dr. Stoller continues to be an active researcher of promising new therapies for retinal diseases including macular degeneration.
Michael Gross, MD
Physician Recommended Nutriceuticals
Dr. Gross graduated from Temple University School of Medicine. He went onto become a board-certified obstetrician and gynecologist. After many years in clinical practice, Dr. Gross switched directions to follow his life-long passion: wellness and prevention. He is a nationally recognized expert in the emerging field of wellness and prevention and has a strong desire to help people avoid disease and reduce the effects of existing conditions. He is currently the Chief Medical Officer for Physician Recommended Nutriceuticals (PRN).
Kristin Protosow, OD
Eye Vision Associates
Dr. Protosow received her Bachelor’s degree in Biology at St. Josephs College on Long Island and her doctorate in optometry from New England College of Optometry in Boston, MA in 2007. She completed her residency at West Haven VA in Connecticut, the largest veteran’s blind center in the northeast. Dr. Protosow was trained in ocular disease and worked closely with retinal, corneal, glaucoma, and oculoplastic specialists. She completed a fellowship with the American Academy of Optometry in 2009. She is certified to practice low vision in the state of New York. She enjoys working with the partially sighted and legally blind in private practice. Dr. Protosow works at Eye Vision Associates.
Daniel Kiernan, MD
Dr. Kiernan is an ophthalmologist specializing in medical and surgical diseases of the retina. He graduated from The University of Chicago with a Bachelor’s degree in Biology. He received his Doctorate in Medicine from Chicago Medical School/ Rosalind Franklin University and completed his residency in Ophthalmology at The University of Chicago, Pritzker School of Medicine. Dr. Kiernan continues his interests in investigating both non-invasive and surgical approaches for the diagnosis and treatment of sight debilitating retinal diseases, including age-related macular degeneration, diabetic retinopathy, and retinal blood vessel occlusions. He is a member of many professional societies and is a reviewer of several peer-reviewed ophthalmology journals.
Registration starts at 8:00 am with Exhibitions. The lectures will begin promptly at 8:30 am. Mid morning refreshments will be provided. At the end of each of the lectures you will have 10 minutes for questions and answers.
Seating is very limited: Registration is FREE but required. Register by phone toll free at 1-800-253-0985, by email email@example.com or you can register here.
When & Where
Macular Degeneration Association
The Macular Degeneration Association is a nonprofit health organization providing macular research, information and advocacy. MDA is an IRS recognized 501(c)3 organization and contributions are tax-deductible to the extent permitted by law.
The mission of the organization is to cure macular degeneration and to improve the lives of all people affected by the disease.
To fulfill this mission, the MDA will fund research, publish scientific findings, provide funding for education, information and other services to people with macular degeneration, their families, healthcare professionals and the public. The foundation advocates for the increase in funding for scientific research and for the rights of people with macular degeneration.
The money raised by the foundation funds research,education, information programs and advocacy and awareness efforts that will support the over 9.1 million people with macular degeneration in communities across America.